ABL Europe’s facilities in Strasbourg (4,500 m2) and Lyon (6,500 m2) are GMP licensed in accordance with the European Medicines Agency (EMA) for the manufacture of gene therapy products.
Both sites have large scale drug substance adherent and suspension capabilities, offering manufacturing & scheduling flexibility through all stages of clinical supply & commercialisation.
Roller Bottles < 17 m2
Cell Stacks < 60 m2 (Cell Factories, CellSTACKs and HYPERStacks)
Stirred SUB 200 L and 500 L